Skip to main content
NCBI home page
Gut logoLink to Gut
. 1993 Dec;34(12):1662–1665. doi: 10.1136/gut.34.12.1662

Two year maintenance treatment of duodenal ulcer disease with ranitidine 150 mg: a prospective multicentre randomised study. GEMUD (Groupe d'Etude de la Maladie Ulcéreuse Duodénale).

P Ruszniewski 1, A Slama 1, M Pappo 1, M Mignon 1
PMCID: PMC1374458  PMID: 8282251

Abstract

Maintenance treatment of duodenal ulcer (DU) with ranitidine 150 mg/day was compared with placebo in a two year prospective multicentre randomised study. Three hundred and ninety nine patients were included (mean age: 44.7 years, M/F ratio = 2.47/1; 37.6% of smokers) in placebo (n = 202) and ranitidine (n = 197) groups. Efficacy was assessed by the length of time to the first ulcer pain attack (with or without endoscopic confirmation) or DU complication. One hundred and fourteen patients of 399 (28.6%) had incomplete follow up. Actuarial survival curves of patients without ulcer pain (26 and 53% at two years in placebo and ranitidine groups, respectively) were significantly different (p < 0.0001). Endoscopies were performed depending on physicians' decision (mainly where there was severe pain or complication). Patients without relapses from endoscopy were more frequent in the ranitidine group (83%) than in the placebo group (47%, p < 0.0001). A greater incidence of complications, mainly bleeding, was also seen in the placebo group (13 complications v two in the ranitidine group, p < 0.002). No factor predicting DU relapse was identified. No important side effect was encountered. Ranitidine 150 mg/day is effective and well tolerated in preventing ulcer pain attacks and DU complications for up to two years.

Full text

PDF
1662

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bardhan K. D. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Anglo-Irish Cimetidine Long-Term Study Group. Aliment Pharmacol Ther. 1988 Oct;2(5):395–405. doi: 10.1111/j.1365-2036.1988.tb00713.x. [DOI] [PubMed] [Google Scholar]
  2. Bolin T. D., Davis A. E., Billington B. Prevention of duodenal ulcer occurrence. Double-blind comparison of ranitidine and cimetidine. J Clin Gastroenterol. 1987 Jun;9(3):310–313. doi: 10.1097/00004836-198706000-00013. [DOI] [PubMed] [Google Scholar]
  3. Boyd E. J., Penston J. G., Johnston D. A., Wormsley K. G. Does maintenance therapy keep duodenal ulcers healed? Lancet. 1988 Jun 11;1(8598):1324–1327. doi: 10.1016/s0140-6736(88)92131-9. [DOI] [PubMed] [Google Scholar]
  4. Boyd E. J., Wilson J. A., Wormsley K. G. Safety of ranitidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol. 1984 May;19(3):394–400. [PubMed] [Google Scholar]
  5. Bresci G., Capria A., Federici G., Rindi G., Geloni M., Corsini G. Prevention of relapse with various antiulcer drugs. Scand J Gastroenterol Suppl. 1986;121:58–62. doi: 10.3109/00365528609091680. [DOI] [PubMed] [Google Scholar]
  6. Cerulli M. A., Cloud M. L., Offen W. W., Chernish S. M., Matsumoto C. Nizatidine as maintenance therapy of duodenal ulcer disease in remission. Scand J Gastroenterol Suppl. 1987;136:79–83. doi: 10.3109/00365528709094490. [DOI] [PubMed] [Google Scholar]
  7. Chambers J. B., Pryce D., Bland J. M., Northfield T. C. Effect of bedtime ranitidine on overnight gastric acid output and intragastric pH: dose/response study and comparison with cimetidine. Gut. 1987 Mar;28(3):294–299. doi: 10.1136/gut.28.3.294. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Di Mario F., Battaglia G., Saggioro A., Chiozzini P., D'Angelo A., Marin R., Morelli A., Vezzadini P., Buscarini L., Cavassini G. A comparison of nizatidine and ranitidine in the maintenance treatment of duodenal ulcer. A randomized, double blind, multicentre, 2-year study. Ital J Gastroenterol. 1991 Jun;23(5):253–256. [PubMed] [Google Scholar]
  9. Kurata J. H., Koch G. G., Nogawa A. N. Comparison of ranitidine and cimetidine ulcer maintenance therapy. J Clin Gastroenterol. 1987 Dec;9(6):644–650. doi: 10.1097/00004836-198712000-00007. [DOI] [PubMed] [Google Scholar]
  10. Masoero G., Rocchia F., Rossanino A., Marchetto M., Benitti V., De la Pierre M. Comparison of ranitidine and sucralfate in the long-term treatment of duodenal ulcer. J Clin Gastroenterol. 1986 Dec;8(6):624–627. doi: 10.1097/00004836-198612000-00006. [DOI] [PubMed] [Google Scholar]
  11. Mignon M., Ruszniewski P., Pappo M., Alberola B., Georges D. Traitement des poussées ou traitement préventif des récidives dans la maladie ulcéreuse duodénale? Etude contrôlée en double aveugle d'une prise quotidienne de ranitidine 150 mg pendant un an. Gastroenterol Clin Biol. 1990;14(10):732–738. [PubMed] [Google Scholar]
  12. Murray W. R., Cooper G., Laferla G., Rogers P., Archibald M. Maintenance ranitidine treatment after haemorrhage from a duodenal ulcer. A 3-year study. Scand J Gastroenterol. 1988 Mar;23(2):183–187. doi: 10.3109/00365528809103965. [DOI] [PubMed] [Google Scholar]
  13. Palmer R. H., Frank W. O., Karlstadt R. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis. Aliment Pharmacol Ther. 1990 Jun;4(3):283–294. doi: 10.1111/j.1365-2036.1990.tb00473.x. [DOI] [PubMed] [Google Scholar]
  14. Penston J. G., Wormsley K. G. Nine years of maintenance treatment with ranitidine for patients with duodenal ulcer disease. Aliment Pharmacol Ther. 1992 Oct;6(5):629–645. doi: 10.1111/j.1365-2036.1992.tb00577.x. [DOI] [PubMed] [Google Scholar]
  15. Penston J. G., Wormsley K. G. Review article: maintenance treatment with H2-receptor antagonists for peptic ulcer disease. Aliment Pharmacol Ther. 1992 Feb;6(1):3–29. doi: 10.1111/j.1365-2036.1992.tb00541.x. [DOI] [PubMed] [Google Scholar]
  16. Penston J., Wormsley K. G. Efficacy and safety of long-term maintenance therapy of duodenal ulcers. Scand J Gastroenterol. 1989 Nov;24(9):1145–1152. doi: 10.3109/00365528909089269. [DOI] [PubMed] [Google Scholar]
  17. Pounder R. Silent peptic ulceration: deadly silence or golden silence? Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):626–631. doi: 10.1016/s0016-5085(89)80058-7. [DOI] [PubMed] [Google Scholar]
  18. Pym B., Sandstad J., Seville P., Byth K., Middleton W. R., Talley N. J., Piper D. W. Cost-effectiveness of cimetidine maintenance therapy in chronic gastric and duodenal ulcer. Gastroenterology. 1990 Jul;99(1):27–35. doi: 10.1016/0016-5085(90)91225-u. [DOI] [PubMed] [Google Scholar]
  19. Ruszniewski P., Levy E., Mignon M. Analyse économique du traitement d'entretien de la maladie ulcéreuse duodénale par la ranitidine 150 mg. Groupe d'Etude de la Maladie Ulcéreuse Duodénale (GEMUD). Gastroenterol Clin Biol. 1992;16(11):842–847. [PubMed] [Google Scholar]
  20. Wade A. G., Rowley-Jones D. Long term management of duodenal ulcer in general practice: how best to use cimetidine? Br Med J (Clin Res Ed) 1988 Apr 2;296(6627):971–974. doi: 10.1136/bmj.296.6627.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walan A., Bianchi-Porro G., Hentschel E., Bardhan K. D., Delattre M. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol. 1987 May;22(4):397–405. doi: 10.3109/00365528708991481. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES